rs1555462438
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001009944.3(PKD1):c.165_171delGCTGCGG(p.Leu56ArgfsTer15) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001009944.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant polycystic kidney diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polycystic kidney disease 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Caroli diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001009944.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PKD1 | NM_001009944.3 | MANE Select | c.165_171delGCTGCGG | p.Leu56ArgfsTer15 | frameshift | Exon 1 of 46 | NP_001009944.3 | ||
| PKD1 | NM_000296.4 | c.165_171delGCTGCGG | p.Leu56ArgfsTer15 | frameshift | Exon 1 of 46 | NP_000287.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PKD1 | ENST00000262304.9 | TSL:1 MANE Select | c.165_171delGCTGCGG | p.Leu56ArgfsTer15 | frameshift | Exon 1 of 46 | ENSP00000262304.4 | ||
| PKD1 | ENST00000423118.5 | TSL:1 | c.165_171delGCTGCGG | p.Leu56ArgfsTer15 | frameshift | Exon 1 of 46 | ENSP00000399501.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Polycystic kidney disease, adult type Pathogenic:3
Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 5-Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant polycystic kidney disease, predominantly caused by monoallelic variants, with rare reports of bi-allelic variants causing disease. (N) 0201 - Variant is located in exon 1 of 46 and is predicted to cause nonsense-mediated decay (NMD) and loss of protein. (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0701 - Comparable variants have very strong previous evidence for pathogenicity. Many pathogenic NMD-predicted variants in this gene have been reported in ClinVar and ADPKD Mutation Database. (P) 0801 - Strong previous evidence of pathogenicity in unrelated individuals. This variant has been previously reported in individuals with ADPKD (PMID: 27499327; PMID: 31740684) and has been reported as pathogenic in the ADPKD Mutation Database. (P) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign
PVS1, PM2_Supporting, PP4_Strong
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31740684, 22508176, 17582161, 36843311, 37909612, 27499327, 35325889, 38527221)
Polycystic kidney disease Pathogenic:1
The PKD1 p.Leu56ArgfsX15 variant was identified in 3 of 1760 proband chromosomes (frequency: 0.002) from individuals or families with ADPKD (Rossetti 2007, Carrera 2016, Hwang 2016). The variant was also identified in ClinVar (1x as pathogenic by Athena Diagnostics Inc.) and ADPKD Mutation Database (as definitely pathogenic). The variant was not identified in the following databases: dbSNP, LOVD 3.0 and PKD1-LOVD, the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.165_171del variant is predicted to cause a frameshift, which alters the protein amino acid sequence beginning at codon 56 and leads to a premature stop codon 15 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the PKD1 gene are an established mechanism of disease in ADPKD and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at